BAS Annual Meeting 2019 – Keble College, Oxford

“Controversies in Cardiovascular Medicine”

DATES: Thursday 26 – Friday 27 September 2019

LOCATION: Keble College, Oxford

Preliminary program:

HUGH SINCLAIR LECTURE:

Professor Ira TABAS (Columbia University, USA)

“Macrophages and Hepatocytes in Cardiometabolic Disease”

Sessions and speakers (TBC)

NOVEL INSIGHTS FROM LARGE BIOBANKS

  • The latest update from UK Biobank – Rory Collins (Oxford).
  • Novel targets from Mendelian randomization – Aroon HINGORANI (London)

CULPRIT CELLS IN ATHEROSCLEROTIC PLAQUES

  • Smooth muscle cell plasticity – Martin BENNETT (Cambridge)
  • Extravasation of immune cells: Role of neutrophils in atherosclerosis – Oliver SOEHNLEIN (Munich, GERMANY)

INFLAMMATION versus LIPIDS: RESIDUAL INFLAMMATORY RISK

  • IL-1: a success story of an anti-inflammatory target in CVD – Sheila FRANCIS (Sheffield, UK)
  • How to tackle inflammation against oxidized lipids in atherosclerosis – Christoph BINDER (Vienna, AUSTRIA)
  • Effective translation of inflammatory targets – lessons and pitfalls, preclinical models to patients – Andrew BAKER (Edinburgh, UK)

LIPIDS versus INFLAMMATION: RESIDUAL LIPID RISK BEYOND LDL-C

  • The biology of PCSK9: beyond LDLC lowering – Alberico CATAPANO (Milan, ITALY)
  • Novel lipid targets for CVD – Anne TYBJERG-HANSEN (Copenhagen, DENMARK)
  • Lipoprotein (a) and antisense therapy – Sam TSIMIKAS (San Diego, USA)